Takara Bio Inc.
4974.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | ¥112 | ¥97 | ¥100 | ¥126 |
| - Cash | ¥19 | ¥22 | ¥30 | ¥29 |
| + Debt | ¥10 | ¥10 | ¥1 | ¥1 |
| Enterprise Value | ¥103 | ¥85 | ¥71 | ¥99 |
| Revenue | ¥10 | ¥9 | ¥16 | ¥10 |
| % Growth | 2.8% | -41.2% | 65.4% | – |
| Gross Profit | ¥6 | ¥5 | ¥10 | ¥4 |
| % Margin | 58.4% | 54% | 61.5% | 41.2% |
| EBITDA | -¥3 | -¥0 | ¥4 | -¥1 |
| % Margin | -32.3% | -3.3% | 28.5% | -6% |
| Net Income | -¥5 | -¥2 | ¥2 | -¥2 |
| % Margin | -56.7% | -16.3% | 15.4% | -19.9% |
| EPS Diluted | -44.84 | -12.55 | 20.09 | -15.7 |
| % Growth | -257.3% | -162.5% | 228% | – |
| Operating Cash Flow | ¥1 | ¥2 | ¥1 | -¥1 |
| Capital Expenditures | -¥12 | -¥0 | -¥0 | -¥8 |
| Free Cash Flow | -¥11 | ¥2 | ¥1 | -¥10 |